|
32469.01.09
|
ABIRATERONE/STADA F.C.TAB 500MG/TAB BT x 60 tabs σε blister (AL-PVC/PE/PVDC)
|
|
1.264,66 |
1.406,57 |
1.554,33 |
STADA Arzneimittel AG
|
|
32845.01.03
|
AXITINIB/STADA F.C.TAB 1MG/TAB BT X 56 TABS ΣΕ BLISTER (OPA/ALU/PVC/ALU)
|
|
303,66 |
337,74 |
393,80 |
STADA Arzneimittel AG
|
|
32845.01.04
|
AXITINIB/STADA F.C.TAB 1MG/TAB BT X 60 TABS ΣΕ BLISTER (OPA/ALU/PVC/ALU)
|
|
325,35 |
361,86 |
421,93 |
STADA Arzneimittel AG
|
|
32845.02.03
|
AXITINIB/STADA F.C.TAB 5MG/TAB BT X 56 TABS ΣΕ BLISTER (OPA/ALU/PVC/ALU)
|
|
1.518,29 |
1.688,66 |
1.857,10 |
STADA Arzneimittel AG
|
|
32845.02.04
|
AXITINIB/STADA F.C.TAB 5MG/TAB BT X 60 TABS ΣΕ BLISTER (OPA/ALU/PVC/ALU)
|
|
1.626,75 |
1.809,28 |
1.980,16 |
STADA Arzneimittel AG
|
|
32627.01.01
|
AZACITIDINE/STADA PD.INJ.SUS 25MG/ML BTx 1 VIAL (GLASS) x 100MG
|
|
125,93 |
144,76 |
178,00 |
STADA Arzneimittel AG
|
|
32627.01.02
|
AZACITIDINE/STADA PD.INJ.SUS 25MG/ML BTx 1 VIAL (GLASS) x 150MG
|
|
192,19 |
213,76 |
253,77 |
STADA Arzneimittel AG
|
|
32507.01.01
|
BORTEZOMIB/STADA INJ.SOL 2.5MG/ML BTx1VIAL (GLASS - TYPE 1) x 10ML περιέχει 1,4ml διαλύματος
|
|
184,57 |
205,28 |
243,70 |
STADA Arzneimittel AG
|
|
33028.02.02
|
DABIGATRAN ETEXILATE/STADA CAPS 110MG/CAP BT X 30 CAPS (PERFORATED ALUMINUM/OPA-ALU-PVC UNIT DOSE BLISTERS 10 X 1)
|
|
12,78 |
14,68 |
20,22 |
STADA Arzneimittel AG
|
|
33028.03.02
|
DABIGATRAN ETEXILATE/STADA CAPS 150MG/CAP BT X 30 CAPS (PERFORATED ALUMINUM/OPA-ALU-PVC UNIT DOSE BLISTERS 10 X 1)
|
|
13,00 |
14,95 |
20,60 |
STADA Arzneimittel AG
|
|
32927.01.01
|
DIMETHYL FUMARATE/STADA GR.CAP 120MG/CAP BT X 14 CAPS ΣΕ BLISTER (OPA/ALU/PVC//ALU)
|
|
50,65 |
58,22 |
74,05 |
STADA Arzneimittel AG
|
|
32927.02.13
|
DIMETHYL FUMARATE/STADA GR.CAP 240MG/CAP BT X 100 CAPS ΣΕ BOTTLE (HDPE)
|
|
596,30 |
663,21 |
752,21 |
STADA Arzneimittel AG
|
|
32927.02.02
|
DIMETHYL FUMARATE/STADA GR.CAP 240MG/CAP BT X 28 CAPS ΣΕ BLISTER (OPA/ALU/PVC//ALU)
|
|
189,73 |
211,02 |
250,52 |
STADA Arzneimittel AG
|
|
32927.02.03
|
DIMETHYL FUMARATE/STADA GR.CAP 240MG/CAP BT X 56 CAPS ΣΕ BLISTER (OPA/ALU/PVC//ALU)
|
|
379,47 |
422,05 |
487,63 |
STADA Arzneimittel AG
|
|
32927.02.04
|
DIMETHYL FUMARATE/STADA GR.CAP 240MG/CAP BT X 60 CAPS ΣΕ BLISTER (OPA/ALU/PVC//ALU)
|
|
406,57 |
452,19 |
522,46 |
STADA Arzneimittel AG
|
|
32875.01.02
|
FINGOLIMOD/STADA CAPS 0.5MG/CAP BT X 28 ΣΕ BLISTER PVC/PVDC/ALU
|
|
598,62 |
665,79 |
755,14 |
STADA Arzneimittel AG
|
|
32875.01.03
|
FINGOLIMOD/STADA CAPS 0.5MG/CAP BT X 30 ΣΕ BLISTER PVC/PVDC/ALU
|
|
641,37 |
713,33 |
805,28 |
STADA Arzneimittel AG
|
|
32231.02.08
|
FORDIAB F.C.TAB (50+1000)MG/TAB BT x 100 tabs σε bottles (HDPE)
|
|
16,77 |
19,28 |
26,56 |
STADA Arzneimittel AG
|
|
32231.02.05
|
FORDIAB F.C.TAB (50+1000)MG/TAB BT x 60 tabs σε blister (PVC-PVDC/AL)
|
|
11,44 |
13,15 |
18,13 |
STADA Arzneimittel AG
|
|
32231.01.08
|
FORDIAB F.C.TAB (50+850)MG/TAB BT x 100 tabs σε bottles (HDPE)
|
|
22,44 |
25,79 |
35,54 |
STADA Arzneimittel AG
|
|
32231.01.05
|
FORDIAB F.C.TAB (50+850)MG/TAB BT x 60 tabs σε blister (PVC-PVDC/AL)
|
|
15,30 |
17,58 |
24,22 |
STADA Arzneimittel AG
|
|
32858.01.04
|
HUKYNDRA INJ.SOL 40MG/0.4ML 1 PF.PEN + 1 ΕΠΙΘΕΜΑ ΑΛΚΟΟΛΗΣ
|
|
182,36 |
209,62 |
248,86 |
STADA Arzneimittel AG
|
|
32858.01.01
|
HUKYNDRA INJ.SOL 40MG/0.4ML 1 PF.SYR + 1 ΕΠΙΘΕΜΑ ΑΛΚΟΟΛΗΣ
|
|
182,36 |
209,62 |
248,86 |
STADA Arzneimittel AG
|
|
32858.02.01
|
HUKYNDRA INJ.SOL 80MG/0.8ML 1 PF.SYR + 1 ΕΠΙΘΕΜΑ ΑΛΚΟΟΛΗΣ
|
|
341,83 |
380,19 |
443,30 |
STADA Arzneimittel AG
|
|
33203.01.01
|
KINPEYGO MOD.R.CA.H 4MG/CAP BT X 1 ΦΙΑΛΗ (HDPE) X 120 ΚΑΨΑΚΙΑ
|
|
5.936,18 |
6.602,26 |
7.138,37 |
STADA Arzneimittel AG
|
|
32624.04.01
|
LENALIDOMIDE/STADA CAPS 10MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
|
1.591,59 |
1.770,18 |
1.937,37 |
STADA Arzneimittel AG
|
|
32624.05.01
|
LENALIDOMIDE/STADA CAPS 15MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
|
1.677,86 |
1.866,13 |
2.042,39 |
STADA Arzneimittel AG
|
|
32624.06.01
|
LENALIDOMIDE/STADA CAPS 20MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
|
2.123,91 |
2.362,23 |
2.572,82 |
STADA Arzneimittel AG
|
|
32624.07.01
|
LENALIDOMIDE/STADA CAPS 25MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
|
2.113,73 |
2.350,90 |
2.560,48 |
STADA Arzneimittel AG
|
|
32624.02.01
|
LENALIDOMIDE/STADA CAPS 5MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
|
1.628,32 |
1.811,02 |
1.982,07 |
STADA Arzneimittel AG
|
|
33111.01.04
|
LIBMYRIS INJ.SOL 40MG/0.4ML 1 PF. PEN + 1 ΕΠΙΘΕΜΑ ΑΛΚΟΟΛΗΣ
|
|
122,80 |
141,15 |
173,55 |
STADA Arzneimittel AG
|
|
33111.01.01
|
LIBMYRIS INJ.SOL 40MG/0.4ML 1 PF.SYR + 1 ΕΠΙΘΕΜΑ ΑΛΚΟΟΛΗΣ
|
|
122,80 |
141,15 |
173,55 |
STADA Arzneimittel AG
|
|
33111.02.01
|
LIBMYRIS INJ.SOL 80MG/0.8ML 1 PF.SYR + 1 ΕΠΙΘΕΜΑ ΑΛΚΟΟΛΗΣ
|
|
156,83 |
180,27 |
217,84 |
STADA Arzneimittel AG
|
|
32292.01.01
|
MOVYMIA INJ.SOL 20 mcg/80 μl 1 φυσίγγιο x 2.4 ML
|
|
121,80 |
140,00 |
172,14 |
STADA Arzneimittel AG
|
|
32292.01.03
|
MOVYMIA INJ.SOL 20 mcg/80 μl 1 φυσίγγιο x 2.4 ML + 1 πένα
|
|
121,80 |
140,00 |
172,14 |
STADA Arzneimittel AG
|
|
32292.01.02
|
MOVYMIA INJ.SOL 20 mcg/80 μl 3 φυσίγγια x 2.4 ML
|
|
462,10 |
513,95 |
588,37 |
STADA Arzneimittel AG
|
|
26107.03.01
|
OROCIL LIDO LOZ (1+1)MG/LOZ BTx24 LOZ (3BLISTx8)
|
|
|
|
4,91 |
STADA Arzneimittel AG
|
|
26107.01.01
|
OROCIL LIDO MOUTH SPR (0,2%+0,15%) W/V BT x FL x 30 ML
|
|
|
|
6,02 |
STADA Arzneimittel AG
|
|
32703.01.01
|
OYAVAS C/S.SOL.IN 25MG/ML 1 VIAL x 4 ML
|
|
155,27 |
178,48 |
215,68 |
STADA Arzneimittel AG
|
|
32703.01.02
|
OYAVAS C/S.SOL.IN 25MG/ML VIAL x 16 ML
|
|
600,61 |
668,01 |
757,66 |
STADA Arzneimittel AG
|
|
33252.02.01
|
PALIPERIDONE PALMITATE/STADA INJ.SU.PRO 100MG/PF.SYR BT X 1 PF.SYR X 2 NEEDLES
|
|
110,52 |
127,05 |
156,22 |
STADA Arzneimittel AG
|
|
33252.03.01
|
PALIPERIDONE PALMITATE/STADA INJ.SU.PRO 150MG/PF.SYR BT X 1 PF.SYR X 2 NEEDLES
|
|
163,34 |
187,75 |
226,88 |
STADA Arzneimittel AG
|
|
33252.01.01
|
PALIPERIDONE PALMITATE/STADA INJ.SU.PRO 75MG/PF.SYR BT X 1 PF.SYR X 2 NEEDLES
|
|
86,75 |
99,72 |
126,84 |
STADA Arzneimittel AG
|
|
32603.01.03
|
PAZOPANIB/STADA F.C.TAB 200MG/TAB BT X 90 TABS (ΣΕ BLISTERS ALU-PVC/PE/PVDC)
|
|
1.067,74 |
1.187,55 |
1.321,75 |
STADA Arzneimittel AG
|
|
32603.02.02
|
PAZOPANIB/STADA F.C.TAB 400MG/TAB BT X 60 TABS (ΣΕ BLISTERS ALU-PVC/PE/PVDC)
|
|
1.359,15 |
1.511,66 |
1.662,45 |
STADA Arzneimittel AG
|
|
32533.01.02
|
PITAVASTATIN/STADA F.C.TAB 1MG/TAB BT x 28 TABS (σε BLISTERS ALU//ALU)
|
|
5,80 |
6,67 |
9,19 |
STADA Arzneimittel AG
|
|
32533.02.01
|
PITAVASTATIN/STADA F.C.TAB 2MG/TAB BT x 28 TABS (σε BLISTERS ALU//ALU)
|
|
9,21 |
10,58 |
14,58 |
STADA Arzneimittel AG
|
|
32533.03.01
|
PITAVASTATIN/STADA F.C.TAB 4MG/TAB BT x 28 TABS (σε BLISTERS ALU//ALU)
|
|
16,34 |
18,78 |
25,87 |
STADA Arzneimittel AG
|
|
32348.01.09
|
POSACONAZOLE/STADA GR.TAB 100MG/TAB BT x 24 tabs σε Blisters (PVC/PE/PVdc-ALU)
|
|
297,03 |
330,36 |
385,20 |
STADA Arzneimittel AG
|
|
32717.01.02
|
RIVAROXABAN/STADA F.C.TAB 10MG/TAB BT X 10 F.C.TAB ΣΕ ΚΥΨΕΛΕΣ PVC/PVDC/AL
|
|
9,70 |
11,15 |
15,37 |
STADA Arzneimittel AG
|
|
32717.01.04
|
RIVAROXABAN/STADA F.C.TAB 10MG/TAB BT X 15 F.C.TAB ΣΕ ΚΥΨΕΛΕΣ PVC/PVDC/AL
|
|
12,86 |
14,78 |
20,37 |
STADA Arzneimittel AG
|
|
32717.02.05
|
RIVAROXABAN/STADA F.C.TAB 15MG/TAB BT X 30 F.C.TAB ΣΕ ΚΥΨΕΛΕΣ PVC/PVDC/AL
|
|
28,18 |
32,39 |
44,64 |
STADA Arzneimittel AG
|
|
32717.03.05
|
RIVAROXABAN/STADA F.C.TAB 20MG/TAB BT X 30 F.C.TAB ΣΕ ΚΥΨΕΛΕΣ PVC/PVDC/AL
|
|
28,18 |
32,39 |
44,64 |
STADA Arzneimittel AG
|
|
32717.04.01
|
RIVAROXABAN/STADA F.C.TAB 20MG/TAB BT X 49 F.C.TAB [42 TAB ΤΩΝ 15MG + 7 TAB ΤΩΝ 20MG] ΣΕ ΚΥΨΕΛΕΣ PVC/PVDC/AL
|
|
47,96 |
55,12 |
70,11 |
STADA Arzneimittel AG
|
|
32217.03.03
|
SITAGLIPTIN/STADA F.C.TAB 100MG/TAB BT X 30 TABS ΣΕ BLISTER PVC/PVDC/ALU
|
|
10,67 |
12,26 |
16,90 |
STADA Arzneimittel AG
|
|
32217.02.03
|
SITAGLIPTIN/STADA F.C.TAB 50MG/TAB BT X 30 TABS ΣΕ BLISTER PVC/PVDC/ALU
|
|
8,72 |
10,03 |
13,82 |
STADA Arzneimittel AG
|
|
32687.03.03
|
TADULAN F.C.TAB 20MG/TAB BT X (4 X 1) TAB ΣΕ UNIT-DOSE BLISTER (AL/PVC/PCTFE/PVC)
|
|
16,04 |
18,53 |
26,52 |
STADA Arzneimittel AG
|
|
33319.01.01
|
TERIFLUNOMIDE/STADA F.C.TAB 14MG/TAB BT X 28 (ΣΕ BLISTER ALU/PVC/ALU/OPA)
|
|
314,32 |
349,59 |
407,62 |
STADA Arzneimittel AG
|
|
33628.01.01
|
UZPRUVO INJ.SO.PFS 45MG/0,5ML (90MG/ML) BT X 1 P.F.SYR X 0.5ML
|
|
1.973,59 |
2.195,04 |
2.396,54 |
STADA Arzneimittel AG
|
|
33628.02.01
|
UZPRUVO INJ.SO.PFS 90MG/ML BT X 1 P.F.SYR X 1ML
|
|
2.011,01 |
2.236,65 |
2.441,98 |
STADA Arzneimittel AG
|
|
02164.07.04
|
VENORUTON EF.TAB 1000MG/TAB BTx 30 (TUB 2 x 15)
|
|
|
|
15,97 |
STADA Arzneimittel AG
|
|
02164.05.02
|
VENORUTON TAB 500MG/TAB BTX 60 (blister pvc)
|
|
|
|
17,50 |
STADA Arzneimittel AG
|
|
02164.05.01
|
VENORUTON TAB 500MG/TAB BTX30 (blister PVC)
|
|
|
|
9,44 |
STADA Arzneimittel AG
|
|
33208.01.02
|
XIMLUCI INJ.SOL 10MG/ML BT X 1 VIAL X 0,23ML + 1 ΔΙΗΘΗΤΙΚΗ ΒΕΛΟΝΗ
|
|
426,91 |
474,81 |
548,59 |
STADA Arzneimittel AG
|
|
32373.01.02
|
ΦΕΣΟΤΕΡΟΔΙΝΗ/STADA PR.TAB 4MG/TAB BT X 28 TABS ΣΕ BLISTERS OPA/ALU/PVC-ALU
|
|
9,03 |
10,38 |
14,30 |
STADA Arzneimittel AG
|
|
32373.02.02
|
ΦΕΣΟΤΕΡΟΔΙΝΗ/STADA PR.TAB 8MG/TAB BT X 28 TABS ΣΕ BLISTERS OPA/ALU/PVC-ALU
|
|
10,46 |
12,02 |
16,57 |
STADA Arzneimittel AG
|
